Medical Devices Vigilance Market Size & Share 2019 - 2025
Market Size by Delivery Mode (On-demand, On-premise), by Application (Diagnostic, Therapeutic, Surgical, Research), by End User (Clinical Research Organizations [CROs], Original Equipment Manufacturers [OEMs], Business Process Outsourcing [BPO]), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast.
Download Free PDF

Medical Devices Vigilance Market Size
Medical devices vigilance market size was valued at USD 52.8 billion in 2018 and is expected to witness 8.2% CAGR from 2019 to 2025.
Surge in the number of medical device recalls due to safety issues is the key factor driving the global market growth during the forecast period. According to FDA, in 2015, around 1.4 million adverse events reported in the U.S. agency were sent to the FDA through medical device reporting system. Growing awareness among people pertaining to availability of medical device vigilance software and reporting of adverse events will positively influence medical devices vigilance industry growth over the analysis timeframe.
Additionally, favourable government scenario pertaining to medical devices vigilance to ensure patient safety will serve to be another impact rendering factor that will foster the business growth. Increasing burden on medical devices manufacturers to produce safe medical equipment as well as stringent safety regulations laid by regulatory authorities pertaining to pre- and post-commercialization of medical devices will further spur the market size. However, negligence of manufacturing companies towards product safety may restrain medical devices vigilance industry growth over the coming years.
Medical Devices Vigilance Market Analysis
On-demand delivery mode segment held 80.2% revenue share in 2018 and is projected to witness robust growth during the forthcoming years. Companies such as AssurX, AB-Cube focus on development of advanced cloud-based quality management software systems will increase its adoption over the forecast period.
On-premise delivery mode segment accounted for USD 10.4 billion in 2018 and will witness considerable growth over the coming years. However, shift from on-premises to cloud-based systems owing to technological advancement may negatively impact business growth during the upcoming years.
Diagnostic application segment dominated the medical devices vigilance market with 32.5% revenue share in 2018 and is estimated to witness similar growth during the analysis period. Growing disease burden across the globe increases the demand for diagnostic medical devices. Safety issues pertaining to diagnostic devices such as endoscopes may lead to serious microbial infections that may be life threatening for the patients. Aforementioned factors will escalate the segmental growth during the forthcoming years.
Research application segment is estimated to show lucrative CAGR of 8.5% over the forecast period. Growing investments by public sector has accelerated the pace of R&D in healthcare. Wide range of medical devices involved in R&D activities will increase the need to ensure safety of these devices thereby fostering the segmental growth.
Original equipment manufacturers (OEMs) segment accounted for more than 45% revenue share in 2018 and will witness significant growth over the forecast timeframe. Increasing number of adverse events related to medical devices will surge adoption of medical device vigilance systems among the manufacturers thus, positively influencing the business growth.
Business process outsourcing (BPO) segment held significant revenue share in 2018 and is estimated to show 9.0% CAGR over the analysis period. Growing trend of companies towards outsourcing vigilance activities and retaining its focus on company’s core competencies will favor segmental growth. Increasing adoption of medical device vigilance software by business process outsourcing firms will further escalate revenue growth.
North America market dominated the global market with 33.7% revenue share in 2018 and the high revenue can be attributed to the high demand for medical devices vigilance in the region. Growing number of adverse events reported will increase adoption of vigilance systems in the region. Strong foothold of medical devices manufacturing companies in the region will further augment regional business growth.
Asia Pacific market is estimated to witness lucrative CAGR of 9.8% over the forecast period owing to increasing focus of medical device manufacturers on product safety. Additionally, presence of large and diverse patient pool in the region coupled with surge in clinical research outsourcing will further accelerate regional industry growth.
Medical Devices Vigilance Market Share
Notable industry players operating in the global market include
Industry players focus on strategic alliance such as mergers, collaboration, partnerships as well as novel offerings to capitalize on market opportunities and sustain competition. For instance, AssurX introduced AssurX Cloud QMS, a cloud-based quality management software system. The software ensures faster production of better products by monitoring and managing quality of medical devices across operations in a single centralized as well as streamlined system.
Medical Devices Vigilance Industry Background
The medical devices vigilance market can be traced back in 1992 when the Global Harmonization Task Force (GHTF) that was conceived, to achieve standardization among the national medical device regulatory systems. It aimed at increasing access to effective, safe, as well as clinically beneficial medical technologies. In 2006, the Medical Device Regulation Bill was endorsed to consolidate medical devices laws as well as establish Medical Device Regulatory Authority of India.
With advent of new technology, medical devices vigilance system is projected to remain in growth phase during the forthcoming years. Currently, focus of companies on development of advanced medical devices vigilance systems to ensure safety and efficiency will further ensure industry growth over the forecast period.
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →